Associate Director, Oncology Lifecycle Management - Hematologic Oncology

Natera

12h•Remote

About The Position

Natera is a global leader in cell-free DNA testing focused on changing the management of disease in reproductive health, oncology, and organ transplantation. Signatera is a personalized, tumor-informed test for molecular residual disease (MRD) assessment and surveillance monitoring in patients previously diagnosed with cancer. Signatera is covered by Medicare for colorectal cancer, muscle invasive bladder cancer, high-risk breast cancer, ovarian cancer, lung cancer, and immunotherapy response monitoring for any solid tumor. As an Associate Director of Oncology Lifecycle Management for Hematologic Malignancies, you will work in a highly matrixed environment to help shape the strategic direction and drive execution for company success in Hematologic Oncology.

Requirements

Bachelor’s degree with 5+ years of relevant experience
5+ years experience in product marketing, market analytics at a pharmaceutical / biotech company
Working knowledge of oncology molecular testing / biomarkers

Nice To Haves

Advanced degree preferred (MBA or PhD)
Hematologic oncology experience strongly preferred
Previous KOL management experience preferred

Responsibilities

Own the lifecycle planning and successful product launch for a diagnostic portfolio in Hematologic Malignancies, including Lymphoma, Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL), collaborating with cross-functional teams to develop and execute a strategic plan that drives usage, awareness, and advocacy across key stakeholders worldwide.
Lead a MM/CLL Lifecycle Team that is a cross-functional team accountable for progress on tumor goals and deploying resources to maximize outcomes.
Establish tumor-specific goals to be owned by the lifecycle team and across functions.
Serve as a critical member of clinical/medical teams, helping define and prioritize key indications while identifying and addressing evidence gaps.
Serve as a critical member on commercial subteams, helping to maximize Natera potential by escalating and addressing critical barriers that limit commercial adoption.
Maintain a deep expertise in the Hematology Oncology space by integrating real-time customer insights, publications, data presentations, competitive and market intelligence.
Drive market access efforts, leading the development of reimbursement dossiers for Medicare/MolDx and commercial payers to secure coverage for non-covered indications.
Develop and execute KOL engagement strategies, collaborating with marketing and medical teams to gather insights, build relationships, and foster advocacy.
Shape the value proposition for Natera’s oncology products in collaboration with Medical Affairs and Commercial Marketing, leveraging clinical evidence and market dynamics.
Co-lead advisory boards and market research efforts in partnership with Medical Affairs.
Regularly present strategic plans and progress to executive leadership.